Source: International Congress 2017 – Lung transplant outcomes



Rating:

Share or cite this content

Citations should be made in the following way:
A. Costa-Pozza (Dublin, Ireland). Could LDH monitoring after lung transplantation be used as screening tool for post-transplant lymphoproliferative disorder (PTLD)?. 2468

Member's Comments

No comment yet.

Related content which might interest you: The role of EBV DNAemia in the assessment of post-transplant lymphoproliferative disorders (PTLD) Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings Year: 2009 Medical complications of lung transplantation Source: Eur Respir J 2004; 23: 334-342 Year: 2004 Pulmonary graft-versus-host disease (GVHD) post- stem cell transplant (SCT) for haematological malignancies: Good response to treatment if diagnosed early Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Post-transplant lymphoproliferative disease and other malignancies Source: Eur Respir Mon; 2009: 45: 226–237 Year: 2009 Lymphoma's and rejection after lung transplantation: balancing the immunosuppression Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression Year: 2005 Sixteen years‘ experience of lymphoproliferative disease following lung transplantation Source: Eur Respir J 2007; 30: Suppl. 51, 174s Year: 2007 Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD) Source: International Congress 2018 – Rare lung diseases Year: 2018 Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Lung transplantation (LT) for late onset of non infectious pulmonary complications (LONIPC) after haematopoietic stem cell transplantation (HSCT): Results from a French adult cohort Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Assessment of the restrictive allograft syndrome in patients after lung transplantation Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012 Pulmonary involvement in haematological disorders and bone marrow transplant recipients Source: Eur Respir Monogr 2019; 86: 333-358 Year: 2019 Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease Year: 2016 Pulmonary function testing pre and after allogeneic hematopoietic cell transplantation for hematological malignancies Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Rapid decline in lung disease other than COPD: when should lung transplantation be considered? Source: Annual Congress 2007 - Rapid decline in lung function and its consequences Year: 2007 Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation Source: Eur Respir J 2016; 48: 1807-1810 Year: 2016 CMV management in lung transplant recipients Source: School Course 2012 - Lung Transplantation Year: 2012 Specificities of the paediatric lung transplant recipient Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005 Treatment options in chronic GVHD and CLAD post lung transplantation Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities Year: 2016